Largest companies by net assets
net assets
| Company | Net assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 601 | $3.16M | Healthcare | Medical Devices | United States | Nasdaq |
| 602 | $3.13M | Healthcare | Biotechnology | United States | NYSE |
| 603 | $3.12M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 604 | $2.70M | Healthcare | Biotechnology | United States | Nasdaq |
| 605 | $2.63M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 606 | $2.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 607 | $2.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 608 | $2.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 609 | $2.25M | Healthcare | Medical Devices | United States | Nasdaq |
| 610 | $2.00M | Healthcare | Medical Devices | United States | Nasdaq |
| 611 | $1.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 612 | $1.86M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 613 | $1.80M | Healthcare | Pharmaceuticals | United States | NYSE |
| 614 | $1.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 615 | $1.74M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 616 | $1.72M | Healthcare | Medical Devices | United States | NYSE |
| 617 | $1.52M | Healthcare | Medical Devices | United States | Nasdaq |
| 618 | $1.41M | Healthcare | Biotechnology | United States | Nasdaq |
| 619 | $1.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 620 | $1.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 621 | $0.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 622 | $0.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 623 | $0.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 624 | $0.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 625 | $0.30M | Healthcare | Biotechnology | United States | Nasdaq |
| 626 | $0.04M | Healthcare | Biotechnology | United States | Nasdaq |
| 627 | $0.00M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 628 | $-0.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 629 | $-0.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 630 | $-0.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 631 | $-0.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 632 | $-0.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 633 | $-0.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 634 | $-0.75M | Healthcare | Medical Devices | United States | Nasdaq |
| 635 | $-0.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 636 | $-1.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 637 | $-1.24M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 638 | $-1.74M | Healthcare | Medical Devices | United States | Nasdaq |
| 639 | $-1.74M | Healthcare | Medical Devices | United States | Nasdaq |
| 640 | $-1.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 641 | $-1.78M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 642 | $-2.06M | Healthcare | Medical Devices | United States | Nasdaq |
| 643 | $-2.31M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 644 | $-2.35M | Healthcare | Biotechnology | United States | Nasdaq |
| 645 | $-2.39M | Healthcare | Biotechnology | United States | Nasdaq |
| 646 | $-2.79M | Healthcare | Medical Devices | United States | Nasdaq |
| 647 | $-3.22M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 648 | $-3.40M | Healthcare | Biotechnology | United States | Nasdaq |
| 649 | $-3.52M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 650 | $-3.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 651 | $-3.81M | Healthcare | Medical Devices | United States | Nasdaq |
| 652 | $-4.25M | Healthcare | Pharmaceuticals | United States | NYSE |
| 653 | $-5.10M | Healthcare | Biotechnology | United States | Nasdaq |
| 654 | $-6.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 655 | $-7.43M | Healthcare | Biotechnology | United States | Nasdaq |
| 656 | $-8.89M | Healthcare | Biotechnology | United States | Nasdaq |
| 657 | $-9.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 658 | $-9.97M | Healthcare | Biotechnology | United States | Nasdaq |
| 659 | $-10.39M | Healthcare | Biotechnology | United States | Nasdaq |
| 660 | $-10.42M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 661 | $-11.91M | Healthcare | Pharmaceuticals | United States | NYSE |
| 662 | $-12.05M | Healthcare | Medical Devices | United States | Nasdaq |
| 663 | $-12.07M | Healthcare | Medical Devices | United States | Nasdaq |
| 664 | $-12.78M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 665 | $-14.03M | Healthcare | Biotechnology | United States | Nasdaq |
| 666 | $-14.68M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 667 | $-15.36M | Healthcare | Pharmaceuticals | United States | NYSE |
| 668 | $-15.87M | Healthcare | Medical Devices | United States | Nasdaq |
| 669 | $-16.56M | Healthcare | Biotechnology | United States | Nasdaq |
| 670 | $-17.76M | Healthcare | Healthcare Providers | United States | NYSE |
| 671 | $-18.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 672 | $-23.04M | Healthcare | Biotechnology | United States | Nasdaq |
| 673 | $-24.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 674 | $-27.13M | Healthcare | Medical Devices | United States | Nasdaq |
| 675 | $-27.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 676 | $-27.84M | Healthcare | Medical Devices | United States | Nasdaq |
| 677 | $-30.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 678 | $-30.90M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 679 | $-32.16M | Healthcare | Diagnostics & Research | United States | NYSE |
| 680 | $-32.67M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 681 | $-33.21M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 682 | $-34.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 683 | $-35.26M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 684 | $-35.32M | Healthcare | Biotechnology | United States | Nasdaq |
| 685 | $-35.57M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 686 | $-37.00M | Healthcare | Biotechnology | United States | Nasdaq |
| 687 | $-38.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 688 | $-51.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 689 | $-52.98M | Healthcare | Biotechnology | United States | Nasdaq |
| 690 | $-56.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 691 | $-81.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 692 | $-94.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 693 | $-95.91M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 694 | $-103.32M | Healthcare | Biotechnology | United States | Nasdaq |
| 695 | $-125.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 696 | $-132.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 697 | $-138.57M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 698 | $-145.46M | Healthcare | Biotechnology | — | Nasdaq |
| 699 | $-161.84M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 700 | $-164.85M | Healthcare | Biotechnology | — | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 725 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.